Time-varying association between cigarette and ENDS use on incident hypertension among US adults: a prospective longitudinal study.
Individual Clinical
Safety
Adverse Effects
Cook (2023)
The Impact of Electronic Nicotine Delivery System (ENDS) Flavors on Nicotinic acetylcholine Receptors and Nicotine addiction-Related Behaviors.
Nonclinical
Other Diseases
Addiction
Cooper (2020)
Characterizing ENDS use in young adults with ecological momentary assessment: Results from a pilot study.
Individual Clinical
Consumer Use
Youth Use & Appeal
Cooper (2019)
Flavors Enhance Nicotine Vapor Self-administration in Male Mice.
Nonclinical
Safety Effects In Animals
Non-Clinical Of Nicotine & Cotinine
Cooper (2021)
Chemical Flavorants in Vaping Products alter Neurobiology in a Sex-Dependent Manner to Promote Vaping-Related Behaviors.
Nonclinical
Genotoxicity
In Vivo
Cooper (2023)
Gene Expression alterations in the Bronchial Epithelium of e-Cigarette Users.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Corbett (2019)
Coresta In Vitro Toxicology Taskforce: The Rationale and Strategy For Conducting In Vitro Toxicology Testing of Tobacco Smoke
Nonclinical
Chemical
Methods
Coresta (2004)
CORESTa In Vitro Toxicology Task Force: Report on Interlaboratory Study of the In Vitro Toxicity of Particulate Matter from Four Cigarettes (ames, Neutral Red Cytotoxicity and Micronucleus assays)
Nonclinical
Chemical
Methods
Coresta (2007)
Determination of ammonia in Tobacco and Smokeless Tobacco Products.
Nonclinical
Chemical
Analysis
Coresta (2014)
CORESTa RECOMMENDED METhOD Number 81 ROUTINE aNaLYTICaL MaChINE FOR E-CIGaRETTE aEROSOL GENERaTION aND COLLECTION – DEFINITIONS aND STaNDaRD CONDITIONS
Nonclinical
Chemical
Methods
Coresta (2015)